当前位置:主页 > 医学论文 > 五官科论文 >

咽鼓管成形术治疗咽鼓管功能障碍有效性与安全性的meta分析

发布时间:2019-05-07 05:16
【摘要】:目的:通过系统评价的方法,探讨咽鼓管成形术(ETP)治疗咽鼓管功能障碍(ETD)的有效性和安全性,并进一步比较激光咽鼓管成形术(LETP)和球囊扩张咽鼓管成形术(BET)之间的差异,为ETD的治疗提供循证医学证据。方法:计算机检索中国生物医学数据库、中国知网、万方数据库、维普信息资源系统、Pub Med数据库、EMBASE数据库、MEDLINE数据库,手工检索相关的杂志、会议文献、参考文献等灰色文献,检索时间截止2016年12月,收集所有关于ETP的研究,再从中筛选符合纳入标准和排除标准的文献,用R3.3.2软件对ETP治疗ETD的主观症状总改善率、A型鼓室图总转化率、Valsalva动作总完成率、并发症总发生率进行率的meta分析,并进一步进行亚组分析,比较LETP和BET治疗ETD的主观症状改善率、A型鼓室图转化率、Valsalva动作完成率、并发症发生率的差异。结果:共纳入20篇文献,共有研究对象614例(815耳),10篇文献报道了主观症状改率,17篇文献报道了A型鼓室图转化率,6篇文献报道了Valsalva动作完成率,9篇文献报道了并发症发生率。其主观症状总改善率、A型鼓室图总转化率、Valsalva动作总完成率、并发症总发生率分别为96%(95%CI:0.92~0.99)、65%(95%CI:0.48~0.79)、79%(95%CI:0.65~0.88)和6%(95%CI:0.02~0.12)。亚组分析结果显示:LETP和BET的主观症状改善率分别为98%(95%CI:0.93~1.00)和94%(95%CI:0.87~0.99),P0.05;LETP和BET的A型鼓室图转化率分别为41%(95%CI:0.18~0.68)和76%(95%CI:0.55~0.90),P0.05;LETP和BET的Valsalva动作完成率分别为70%(95%CI:0.59~0.79)和91%(95%CI:0.63~0.98),P0.05;LETP和BET的并发症发生率分别为8%(95%CI:0.02~0.17)和5%(95%CI:0.01~0.14),P0.05。结论:根据本文研究初步得出:(1)ETP治疗成人慢性ETD短期疗效确切,BET与LETP的主观症状改善率无明显差异;BET的A型鼓室图转化率和Valsalva动作完成率均优于LETP,考虑可能与术前患者的中耳状态和术后恢复方式、恢复时间的长短有关。(2)ETP治疗成人慢性ETD安全可行,LETP和BET的并发症发生率差异不明显且均无严重并发症发生。
[Abstract]:Objective: to evaluate the efficacy and safety of eustachian tube angioplasty (ETP) in the treatment of (ETD) with eustachian tube dysfunction. The difference between laser eustachian angioplasty (LETP) and balloon dilated eustachian angioplasty (BET) was further compared in order to provide evidence-based medical evidence for the treatment of ETD. Methods: Chinese biomedicine database, Chinese knowledge website, Wanfang database, Pub Med database, EMBASE database, MEDLINE database, related journals and conference documents were searched by computer. Grey literatures, such as references, were retrieved until December 2016, and all studies on ETP were collected, from which the articles that met the inclusion criteria and exclusion criteria were screened, and the total improvement rate of subjective symptoms of ETP treatment with R3.3.2 software was achieved by using R3.3.2 software. Meta analysis of total conversion rate of type A tympanogram, total completion rate of Valsalva action and total rate of complication were performed, and subgroup analysis was carried out to compare the improvement rate of subjective symptoms, conversion rate of type A tympanogram and complete rate of Valsalva action between LETP and BET in treatment of ETD. Differences in the incidence of complications. Results: a total of 20 articles were included, including 614 cases (815 ears), 10 articles reported the improvement rate of subjective symptoms, 17 articles reported the conversion rate of type A tympanogram, and 6 articles reported the completion rate of Valsalva action. The incidence of complications was reported in 9 articles. The total improvement rate of subjective symptoms, the conversion rate of type A tympanogram, the total completion rate of Valsalva action and the total incidence of complications were 96% (95%CI:0.92~0.99) and 65% (95%CI:0.48~0.79), respectively. 79% (95%CI:0.65~0.88) and 6% (95%CI:0.02~0.12). The results of subgroup analysis showed that the improvement rates of subjective symptoms in LETP and BET were 98% (95%CI:0.93~1.00) and 94% (95%CI:0.87~0.99), P 0.05; The conversion rate of type A tympanogram of LETP and BET was 41% (95%CI:0.18~0.68) and 76% (95%CI:0.55~0.90), P 0.05, respectively. The Valsalva completion rates of LETP and BET were 70% (95%CI:0.59~0.79) and 91% (95%CI:0.63~0.98), P0.05, respectively. The complication rates of LETP and BET were 8% (95%CI:0.02~0.17) and 5% (95%CI:0.01~0.14), P 0.05. Conclusion: (1) the short-term curative effect of ETP on adult chronic ETD is definite, and the improvement rate of subjective symptoms between BET and LETP has no significant difference. The conversion rate of type A tympanogram and the completion rate of Valsalva in BET were better than those in LETP,. (2) ETP is safe and feasible in treating chronic ETD in adults, which may be related to the preoperative middle ear state, the recovery mode and the duration of recovery. (2) the treatment of chronic ETD in adults is safe and feasible. There was no significant difference in the incidence of complications between LETP and BET and no serious complications occurred.
【学位授予单位】:山西医科大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R764.9

【参考文献】

相关期刊论文 前8条

1 王静;方永山;;咽鼓管球囊扩张术治疗症状性咽鼓管功能障碍的可行性分析[J];国际医药卫生导报;2016年23期

2 关兵;王莹;徐丽;曹武;戴炳译;;局麻下咽鼓管球囊扩张术加鼓膜置管术治疗顽固性分泌性中耳炎[J];中国耳鼻咽喉头颈外科;2016年11期

3 杨乐;龚平桂;郑明奋;赵向东;刘昀逸;张军军;范素晓;彭宏;;同期咽鼓管球囊扩张在慢性中耳炎治疗的短期疗效观察[J];中华耳科学杂志;2016年05期

4 肖平;万仁强;符秋养;张学辉;彭宏;;鼻内镜下咽鼓管球囊扩张术治疗延迟开放型咽鼓管功能障碍[J];中华生物医学工程杂志;2016年02期

5 李谊;赵颜颜;麻文来;;咽鼓管球囊扩张术临床应用研究[J];中国医学文摘(耳鼻咽喉科学);2015年06期

6 熊浩;梁茂金;张志钢;许耀东;区永康;陈穗俊;杨海弟;郑亿庆;;咽鼓管球囊扩张术治疗症状性咽鼓管功能障碍的短期效果评价[J];中国耳鼻咽喉头颈外科;2015年10期

7 梁茂金;郑亿庆;张志钢;许耀东;区永康;陈穗俊;杨海弟;黄秋红;邱泽恒;陈玲;;咽鼓管球囊扩张术在咽鼓管功能障碍疾病中的应用[J];临床耳鼻咽喉头颈外科杂志;2014年22期

8 韩开亮;孔娟;宋忠云;王广元;;鼻内镜下咽鼓管扩张导管治疗慢性分泌性中耳炎13例分析[J];山东大学耳鼻喉眼学报;2013年05期



本文编号:2470801

资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/wuguanyixuelunwen/2470801.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户6e8ad***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com